[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556751":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":34,"centralContacts":45,"locations":52,"responsibleParty":68,"collaborators":50,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":50,"eligibilityCriteria":77,"healthyVolunteers":73,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":50,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":50,"overallStatus":55,"whyStopped":50,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Cairo University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"treatment group","EXPERIMENTAL","This group include 30 patients with COPD and intermittent claudication. These patients can receive aerobic exercise (by applying treadmill exercise for 20 min) and inspiratory muscle training (by using The BREATHER device with Light\u002FMedium resistance for 3-5 sets \u002Fsession), for 4 weeks (3 sessions per week) and pursed lip breathing.",[13],"Device: The BREATHER",{"label":15,"type":16,"description":17,"interventionNames":18},"control group","ACTIVE_COMPARATOR","This group include 30 patients with COPD and intermittent claudication. These patients can receive pursed lip breathing and aerobic exercise (by applying treadmill exercise for 20 min) with the usually pharmacological treatment, for 4 weeks (3 sessions per week).",[19],"Drug: pharmacological treatment",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","The BREATHER","The BREATHER is Light\u002FMedium resistance inspiratory muscle trainer which has significance role in increasing inspiratory muscle strength and endurance which could result in a decreased sensation of dyspnea",[9],[27],"experimental group",{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"DRUG","pharmacological treatment","patient will receive the usually pharmacological treatment.",[15],[15],[35,38,40,42],{"name":36,"affiliation":5,"role":37},"Zahra M Serry, Assist.Prof","STUDY_DIRECTOR",{"name":39,"affiliation":5,"role":37},"MARWA M ELSAYED, Assist.Prof",{"name":41,"affiliation":5,"role":37},"Amira I Almeldin, Assist.Prof",{"name":43,"affiliation":5,"role":44},"reem M farahat, student","PRINCIPAL_INVESTIGATOR",[46],{"name":47,"role":48,"phone":49,"phoneExt":50,"email":51},"Reem M Farahat, student","CONTACT","+201050770870",null,"Reemfarahat42@gmail.com",[53],{"facility":54,"status":55,"city":56,"state":50,"zip":50,"country":57,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"Faculty of Physical Therapy","RECRUITING","Dokki","Egypt","EG",{"type":60,"coordinates":61},"Point",[62,63],31.2113,30.03823,{"lat":63,"lon":62},[66],{"name":67,"role":48,"phone":50,"phoneExt":50,"email":50},"Reem Farahat, master",{"type":44,"investigatorFullName":69,"investigatorTitle":70,"investigatorAffiliation":5,"oldNameTitle":50,"oldOrganization":50},"Reem Medhat Mohamed Ali Farahat","demonstrator","100556751","effect-of-breather-in-copd-patients-with-intermittent-claudication-100556751",false,"NCT06529185","Effect of Breather in COPD Patients With Intermittent Claudication","Effect of Breather on Ventilatory and Vascular Function in Chronic Obstructive Pulmonary Disease Patients With Intermittent Claudication.","Inclusion Criteria:\n\n* sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years\n* All patients will be clinically and medically stable when attending the study.\n* Body mass index (BMI) is 18.5 to 24.9 kg\u002Fm2.\n* History of unilateral exertional leg pain,\n* Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad),\n* And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise.\n\nExclusion Criteria:\n\n* cardiovascular insufficiency,\n* Recent myocardial infarction,\n* heart failure,\n* arrhythmia,\n* DVT,\n* Intracranial hypertension,\n* Pneumonia,\n* kidney failure,\n* fractures,\n* uncooperative patients,\n* cognitive impairment preventing a patient from participation in exercises.","MALE","50 Years","60 Years",{"count":82,"type":83},60,"ESTIMATED","INTERVENTIONAL",[86],"NA","The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.",[89,90],"COPD","PAD","2024-12-30",{"date":93,"type":94},"2024-12-31","ACTUAL",{"date":96,"type":94},"2024-07-30",{"date":98,"type":83},"2025-02",{"name":5,"class":6},1]